Number of Shares
172,500.00
Current Holdings Value*
$8.34 Mil
% of Portfolio
0.82%
Total Estimate Gain
$1.32 Mil
% of Total Estimate Gain
3.97%

Affinity Asset Advisors, LLC's Protagonist Therapeutics Inc Holding Summary

As of 2025-03-31, Affinity Asset Advisors, LLC held 172,500.00 shares of Protagonist Therapeutics Inc(PTGX), totaling $8.34 Mil. This investment constitutes 0.82% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 0.28% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.

The initial trade took place in 2021Q1. And since then Affinity Asset Advisors, LLC has made 7 purchases of PTGX, at an average price of $35.40, for a total of 940,100.00 shares. In addition, there have been 3 sales at an average price of $23.34 for 540,100.00 shares. Based on historical transaction data and PTGX's current price of $54.99, Affinity Asset Advisors, LLC's estimated gain on his PTGX holdings is $1.32 Mil, reflecting a 3.97% gain to date.

Affinity Asset Advisors, LLC PTGX ($54.99) Holding Chart

Affinity Asset Advisors, LLC PTGX ($54.99) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1